Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 10, 2018

Quality and future of clinical laboratories: the Vico’s whole cyclical theory of the recurring cycles

  • Mario Plebani ORCID logo EMAIL logo

Abstract

In the last few decades, laboratory medicine has undergone monumental changes, and laboratory technology, which has made enormous advances, now has new clinical applications thanks to the identification of a growing number of biomarkers and risk factors conducive to the promotion of predictive and preventive interventions that have enhanced the role of laboratory medicine in health care delivering. However, the paradigm shift in the past 50 years has led to a gap between laboratory and clinic, with an increased risk of inappropriateness in test request and interpretation, as well as the consolidation of analytical work in focused factories and megastructurers oriented only toward achieving greater volumes, decreasing cost per test and generating a vision of laboratory services as simple commodities. A careful historical revision of the changing models for delivering laboratory services in the United States leads to the prediction that there are several reasons for counteracting the vision of clinical laboratory as a commodity, and restoring the true nature of laboratory services as an integral part of the diagnosis and therapy process. The present study, which reports on internal and external drivers for change, proposes an integrated vision of quality in laboratory medicine.

  1. Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Plebani M. Clinical laboratories: production industry or medical services? Clin Chem Lab Med 2015;53:995–1004.10.1515/cclm-2014-1007Search in Google Scholar PubMed

2. Wright JR Jr. The politics underlying the provision of and changes in pathology and laboratory services in the United States during the roaring twenties. Arch Pathol Lab Med 2016;140:983–91.10.5858/arpa.2016-0113-HPSearch in Google Scholar PubMed

3. Strom CM. Changing trend in laboratory testing in the United States. Clin Lab Med 2012;32:651–64.10.1016/j.cll.2012.07.003Search in Google Scholar PubMed

4. Plebani M. Quality in laboratory medicine: 50 years on. Clin Biochem 2017;50:101–4.10.1016/j.clinbiochem.2016.10.007Search in Google Scholar PubMed

5. Adeli K. Laboratory medicine-a hidden treasure in healthcare. Clin Biochem 2017;50:645–7.10.1016/j.clinbiochem.2017.03.022Search in Google Scholar PubMed

6. Plebani M, EFLM task force on performance specifications for the extra-analytical phases. Performance specifications for the extra-analytical phases of laboratory testing: why and how. Clin Biochem 2017;50:550–4.10.1016/j.clinbiochem.2017.02.002Search in Google Scholar PubMed

7. Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med 2009;361:109–12.10.1056/NEJMp0904131Search in Google Scholar PubMed

8. Plebani M. The changing face of clinical laboratories. Clin Chem Lab Med 1999;37:711–7.10.1515/CCLM.1999.109Search in Google Scholar PubMed

9. Conn RB. Clinical laboratories: profit center, production industry or patient-care resource? N Engl J Med 1978;298:422–7.10.1056/NEJM197802232980804Search in Google Scholar PubMed

10. Price CP, John AS, Christenson R, Scharnhorst V, Oellerich M, Jones P, et al. Leveraging the real value of laboratory medicine with the value proposition. Clin Chim Acta 2016;462:183–6.10.1016/j.cca.2016.09.006Search in Google Scholar PubMed

11. Plebani M, Lippi G. Is laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed. Clin Biochem 2010;43:939–41.10.1016/j.clinbiochem.2010.05.015Search in Google Scholar PubMed

12. Wright JR Jr. The American College of Surgeons, minimum standards for hospitals, and the provision of high-quality laboratory services. Arch Pathol Lab Med 2017;141:704–17.10.5858/arpa.2016-0348-HPSearch in Google Scholar PubMed

13. Davis L. Fellowship of surgeons: a history of the American College of Surgeons. Chicago, IL: American College of Surgeons, 1960.Search in Google Scholar

14. Hospital Information and Service Department, American College of Surgeons. A manual of hospital standardization. https://archive.org/details/Hospital Standardization Manual 1926. Published 1926. Accessed 15 Oct 2017.Search in Google Scholar

15. Vico G. The new science. New York: Cornell University Press Ithaca, 1948.Search in Google Scholar

16. Jones BA, Bekeris LG, Nakhleh RE, Walsh MK, Valenstein PN, College of American Pathologists. Physician satisfaction with clinical laboratory services: a College of American Pathologists Q-probes study of 138 institutions. Arch Pathol Lab Med 2009;133:38–43.10.5858/133.1.38Search in Google Scholar PubMed

17. McCall SJ, Souers RJ, Blond B, Massie L. Physician satisfaction with clinical laboratory services: a College of American Pathologists Q-Probes Study of 81 Institutions. Arch Pathol Lab Med 2016;140:1098–103.10.5858/arpa.2015-0486-CPSearch in Google Scholar PubMed

18. Seaberg RS, Stallone RO, Statland BE. The role of total laboratory automation in a consolidated laboratory network. Clin Chem 2000;46:751–6.10.1093/clinchem/46.5.751Search in Google Scholar

19. Plebani M, Panteghini M. Promoting clinical and laboratory interaction by harmonization. Clin Chim Acta 2014;432:15–21.10.1016/j.cca.2013.09.051Search in Google Scholar PubMed

20. Institute of Medicine. Improving diagnosis in health care. Washington, DC: National Academies of Sciences, Engineering, and Medicine, 2015. Available at http://iom.nationalacademies.org/Reports/2015/Improving-Diagnosis-in-Healthcare.aspx.Search in Google Scholar

21. Dickerson JA, Fletcher AH, Procop G, Keren D, Singh IR, Garcia JJ, et al. Transforming laboratory utilization review into laboratory stewardship: guidelines by the PLUGS National Committee for Laboratory Stewardship. J Appl Lab Med 2017;2: 259–68.10.1373/jalm.2017.023606Search in Google Scholar PubMed

22. Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship- leveraging the laboratory to improve antimicrobial use. J Am Med Assoc 2017; 318:607–8.10.1001/jama.2017.8531Search in Google Scholar PubMed

23. Messacar K, Parker SK, Todd JK, Dominguez SR. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol 2017;55:715–23.10.1128/JCM.02264-16Search in Google Scholar PubMed PubMed Central

24. Pelloso M, Basso D, Padoan A, Fogar P, Plebani M. Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting. J Clin Pathol 2016;69:777–83.10.1136/jclinpath-2015-203447Search in Google Scholar PubMed

25. Eaton KP, Levy K, Soong C, Pahwa AK, Petrilli C, Ziemba JB. Evidence-based guidelines to eliminate repetitive laboratory testing. JAMA Intern Med 2017;177:1833–9.10.1001/jamainternmed.2017.5152Search in Google Scholar PubMed

26. Piva E, Pelloso M, Penello L, Plebani M. Laboratory critical values: automated notification supports effective clinical decision making. Clin Biochem 2014;47:1163–8.10.1016/j.clinbiochem.2014.05.056Search in Google Scholar PubMed

27. Piva E, Sciacovelli L, Pelloso M, Plebani M. Performance specifications of critical results management. Clin Biochem 2017;50:617–21.10.1016/j.clinbiochem.2017.05.010Search in Google Scholar PubMed

28. Bartlett RC. Medical microbiology: quality costs and clinical relevance. New York, NY: Wiley, 1974.Search in Google Scholar

29. Dooris M. Expert voices for change: bridging the silos-towards healthy and sustainable settings for the 21st century. Health Place 2013;20:39–50.10.1016/j.healthplace.2012.11.009Search in Google Scholar PubMed

30. Porter ME. What is value in health care? N Engl J Med 2010;363:2477–81.10.1056/NEJMp1011024Search in Google Scholar PubMed

31. Tahara DC, Green RP. Strategic re-design of team-based patient-focused health care services. Adv Health Care Manag 2014;16:3–22.10.1108/S1474-823120140000016000Search in Google Scholar

32. Rockwell KL. Direct-to-consumer medical testing in the era of value-based care. J Am Med Assoc 2017;317:2485–6.10.1001/jama.2017.5929Search in Google Scholar PubMed

33. Lovett KM, Mackey TK, Liang BA. Evaluating the evidence: direct-to-consumer screening tests advertised online. J Med Screen 2012;19:141–53.10.1258/jms.2012.012025Search in Google Scholar PubMed

34. McGuire AL, Burke W. Health system implications of direct-to-consumer personal genome testing. Public Health Genomics 2011;14:53–8.10.1159/000321962Search in Google Scholar PubMed PubMed Central

35. Cosby K. Medical decision making. In: Croskerry P, Cosby K, Graber M, Singh H, editors. Diagnosis: interpreting the shadows. Boca Raton, FL: CRC Press Taylo & Francis Group, 2017.10.1201/9781315116334Search in Google Scholar

36. Plebani M, Laposata M, Lundberg GD. The brain-to-brain loop concept for laboratory testing 40 years after its introduction. Am J Clin Pathol 2011;136:829–33.10.1309/AJCPR28HWHSSDNONSearch in Google Scholar PubMed

37. Srinivasan D, Desai NR. The impact of the transition from value to value on heart failure care: implications of novel payment models and quality improvement initiatives. J Cardiac Fail 2017;23:615–20.10.1016/j.cardfail.2017.06.005Search in Google Scholar PubMed

38. Bindman AB, Pronovost PJ, Asch DA. Funding innovation ina learning health care system. JAMA 2018;19:119–20.10.1001/jama.2017.18205Search in Google Scholar PubMed

39. Herzlinger RE, Schleicher SM, Mullangi S. Health care delivery innovations that integrate care? Yes!: but integrating what? J Am Med Assoc 2016;315:1109–10.10.1001/jama.2016.0505Search in Google Scholar PubMed

40. Hadker N, Garg S, Costanzo C, van der Helm W, Creeden J. Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective. Hypertens Pregnancy 2013;32:105–19.10.3109/10641955.2011.638958Search in Google Scholar PubMed

41. Di Martino D, Cetin I, Frusca T, Ferrazzi E, Fuse’ F, Gervasi MT, et al. Italian advisory board: sFlt-1/PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic and clinical management. Eur J Obstet Gynecol Reprod Biol 2016;206:70–3.10.1016/j.ejogrb.2016.08.036Search in Google Scholar PubMed

42. Lee J, Tollefson E, Daly M, Kielb E. A generalized health economic and outcomes research model for the evaluation of companion diagnostics and targeted therapies. Expert Rev Pharmacoecon Outcomes Res 2013;13:361–70.10.1586/erp.13.23Search in Google Scholar PubMed

43. The Centre for International Economics. The economic value of pathology: achieving better health, and better use of health resources. www.TheCIE.com.au. Accessed on 21 Dec 2017.Search in Google Scholar

44. Segal L, Dalton AC, Richardson J. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promot Int 1998;13:197–209.10.1093/heapro/13.3.197Search in Google Scholar

45. Plebani M. Analytical quality: an unfinished journey. Clin Chem Lab Med 2018;56:357–359.10.1515/cclm-2017-0717Search in Google Scholar PubMed

46. Vogeser M, Seger C. Irregular analytical errors in diagnostic testing – a novel concept. Clin Chem Lab Med 2018;56:386–96.10.1515/cclm-2017-0454Search in Google Scholar PubMed

47. Clerico A, Belloni L, Carrozza C, Correale M, Dittadi R, Dotti C, et al. A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods. Clin Chem Lab Med 2018;56:397–40210.1515/cclm-2017-0881Search in Google Scholar PubMed

48. Price CP, Wolstenholme J, McGinley P, St John A. Translational health economics: the key to accountable adoption of in vitro diagnostic technologies. Health Serv Manage Res 2017:951484817736727. doi:10.1177/0951484817736727. [Epub ahead of print].10.1177/0951484817736727Search in Google Scholar PubMed

49. Misialek MJ. Valuing value: the changing role of pathologists. Am J Clin Pathol 2014;142:584–5.10.1309/AJCPH1MW8YPKPLARSearch in Google Scholar PubMed

50. Plebani M. Towards a new paradigm in laboratory medicine: the five rights. Clin Chem Lab Med 2016;54:1881–91.10.1515/cclm-2016-0848Search in Google Scholar PubMed

51. Plebani M. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Biochem Rev 2012;33:85–8.10.1016/j.cca.2013.07.033Search in Google Scholar PubMed

52. Lippi G, Plebani M. The add value of laboratory diagnostics: the many reasons why decision-makers should actually care. J Lab Precis Med 2017;2:100.10.21037/jlpm.2017.12.07Search in Google Scholar

Received: 2018-1-4
Accepted: 2018-1-8
Published Online: 2018-2-10
Published in Print: 2018-5-24

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 23.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2018-0009/html
Scroll to top button